Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
Más filtros

Medicinas Tradicionales
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Rehabilitacion (Madr) ; 54(4): 292-295, 2020.
Artículo en Español | MEDLINE | ID: mdl-32680689

RESUMEN

Chronic or recalcitrant plantar fasciitis is a cause of persistent plantar pain. These cases are usually resistant to conventional treatments consisting of exercises, orthoses, shock waves and infiltrations and require a surgical approach. Proximal medial gastrocnemius release is a surgical option that provides satisfactory results, but is not free of complications, which include injuries and nerve entrapment. We report the first published case of symptomatic medial gastrocnemius branch entrapment in the post-surgical scar of a tenotomy for the treatment of recalcitrant plantar fasciitis. We propose ultrasound-guided hydrodissection with local anesthetic as a treatment with promising results.


Asunto(s)
Disección/métodos , Fascitis Plantar/cirugía , Síndromes de Compresión Nerviosa/terapia , Complicaciones Posoperatorias/terapia , Nervio Tibial/lesiones , Ultrasonografía Intervencional , Anestesia Local , Cicatriz/complicaciones , Disección/instrumentación , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Síndromes de Compresión Nerviosa/etiología , Complicaciones Posoperatorias/etiología , Presión , Recurrencia , Soluciones/administración & dosificación , Soluciones/uso terapéutico , Tenotomía/efectos adversos , Escala Visual Analógica
2.
J Emerg Med ; 57(4): 461-468, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31594739

RESUMEN

BACKGROUND: Children presenting to pediatric emergency departments (EDs) are frequently given enemas for relief of constipation symptoms; there is very little literature guiding solution selection. OBJECTIVE: Our aim was to assess and compare the efficacy of the various enema solutions used in a pediatric ED, including the "pink lady," a previously unreported compounded combination of docusate, magnesium citrate, mineral oil, and sodium phosphate. METHODS: We identified all children who received any enema over a 5-year period in an urban, quaternary care pediatric ED for inclusion in the study via electronic record review. Physician investigators retrospectively reviewed routine visit documentation to confirm the type and dosage of enema and assess comorbidities, indications, efficacy, and side effects. Subjective descriptions of output were classified as none, small, medium, or large by reviewer consensus. RESULTS: There were 768 records included. Median age was 6.2 years (interquartile range 3.3-10.3 years). Solutions used were sodium phosphate (n = 396), pink lady (n = 198), soap suds (n = 160), and other (n = 14). There was no significant difference in output by solution type (p = 0.88). Volume delivered was highest for pink lady, with no significant association between volume delivered and output (p = 0.48). Four percent of patients had side effects. Soap suds had a significantly higher rate of side effects (10.6%; p = 0.0003), primarily abdominal pain. CONCLUSIONS: There was no significant difference in reported stool output produced by sodium phosphate, soap suds, and pink lady enemas in children treated in an ED. Further study via randomized controlled trials would be beneficial in guiding selection of enema solution.


Asunto(s)
Enema/instrumentación , Soluciones/química , Resultado del Tratamiento , Análisis de Varianza , Niño , Preescolar , Estreñimiento/tratamiento farmacológico , Servicio de Urgencia en Hospital/organización & administración , Servicio de Urgencia en Hospital/estadística & datos numéricos , Enema/métodos , Femenino , Humanos , Masculino , Pediatría/instrumentación , Pediatría/métodos , Pediatría/estadística & datos numéricos , Estudios Retrospectivos , Soluciones/farmacología , Soluciones/uso terapéutico
3.
Am J Otolaryngol ; 39(3): 307-312, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29551350

RESUMEN

PURPOSE: To demonstrate non-inferiority of eberconazole 1% otic solution to clotrimazole 1% solution, and to compare their safety profiles in the treatment of otomycosis. MATERIALS AND METHODS: Multicenter, randomized, double-blind, active treatment-controlled phase 3 clinical trial. One hundred and ninety patients with diagnosis of otomycosis were randomly assigned to eberconazole 1% otic solution or clotrimazole 1% solution. RESULTS: Baseline characteristics were comparable between both groups for age, gender, ethnicity, and clinical variables. Both study groups had high complete response rates: 81.8% in the eberconazole group and 83.5% in the clotrimazole group. Although non-inferiority of eberconazole relative to clotrimazole could not be demonstrated, a post-hoc sensitivity analysis demonstrated that eberconazole 1% otic solution was not inferior to clotrimazole 1% solution for the primary efficacy endpoint. Secondary endpoints also demonstrated that eberconazole 1% and clotrimazole 1% solutions were therapeutically similar at the end of the study. The incidence of adverse events was similar in both groups, and none had related AEs and withdrawals due to an AE. CONCLUSIONS: Eberconazole 1% otic solution is an efficacious and safe option to treat otomycosis-affected patients in the general practice.


Asunto(s)
Antifúngicos/uso terapéutico , Clotrimazol/uso terapéutico , Cicloheptanos/uso terapéutico , Imidazoles/uso terapéutico , Otomicosis/tratamiento farmacológico , Administración Tópica , Adulto , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Esquema de Medicación , Femenino , Humanos , Masculino , México , Persona de Mediana Edad , Otomicosis/microbiología , Otomicosis/fisiopatología , Seguridad del Paciente , Soluciones/uso terapéutico , Resultado del Tratamiento , Adulto Joven
4.
Neurosurg Rev ; 41(4): 945-956, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28258418

RESUMEN

There is a controversy about the effects of hypertonic saline (HS) used for brain relaxation in patients requiring craniotomies. We conducted a meta-analysis to compare the efficacy of equiosmolar hypertonic saline with mannitol on intraoperative brain relaxation in patients undergoing craniotomies. We searched PubMed, EMBASE, Cochrane Library databases, and Web of Science for randomized controlled trials (RCTs). The outcome indicators included brain relaxation, hemodynamic status, fluid volume, and blood chemistry. A total of nine RCTs involving 665 patients were identified and included. There was a greater increase in the odds of good intraoperative brain relaxation in the HS group (odds ratio (OR) 2.05, 95% confidence interval (CI) 1.40~3.01; P = 0.0002) compared with mannitol. In comparison with HS, mannitol slightly reduced the central venous pressure (CVP) (mean difference (MD) 1.03, 95% CI 0.03~2.03; P = 0.04) as well as significantly increasing the diuretic effect regardless of the dosage of HS (standardized mean difference (SMD) -0.86, 95% CI -1.35~-0.37; P = 0.0006). HS increased the plasma sodium level significantly (MD 7.86, 95% CI 2.78 ~ 12.95, P = 0.002) but reduced the intraoperative fluid intake (SMD -0.56, 95% CI -0.98~-0.15, P = 0.008). However, there were no significant differences in plasma osmolality and mean arterial pressure (MAP). Our results suggest that there appears to be better brain relaxation without a significant increase in urine volume in the HS group compared with mannitol in patients requiring craniotomies. High-quality RCTs with larger sample sizes will be required in the future to confirm the conclusions.


Asunto(s)
Craneotomía/métodos , Diuréticos/uso terapéutico , Manitol/uso terapéutico , Procedimientos Neuroquirúrgicos/métodos , Solución Salina Hipertónica/uso terapéutico , Soluciones/uso terapéutico , Diuréticos/administración & dosificación , Humanos , Manitol/administración & dosificación , Ensayos Clínicos Controlados Aleatorios como Asunto , Solución Salina Hipertónica/administración & dosificación
5.
Actas Urol Esp ; 39(2): 118-21, 2015 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-25262388

RESUMEN

OBJECTIVES: Despite scientific literature mentions the application of "water of the 3 sulfates" (copper sulphate, zinc sulphate and alum) as a treatment for acute balanitis and balanoposthitis, no clinical trials evaluating its efficacy have been found. In our study we evaluate the efficacy of this solution in acute balanitis and balanoposthitis. MATERIAL AND METHODS: A double-blind randomized study was designed to compare the efficacy of "water of the 3 sulfates" (intervention) with saline solution (control) in 50 patients (30 patients and 20 patients, respectively) who suffer from acute balanitis or balanoposthitis. Exudate, erythema, oedema, burning, and itching were the clinical parameters assessed. RESULTS: for all clinical parameters assessed, the outcomes obtained with "water of the 3 sulfates" are higher than control, although significant differences only have been found for exudate. CONCLUSIONS: in our study, the "water of the 3 sulfates" is significantly more effective than saline solution for removing exudates in acute balanitis and balanoposthitis. Tolerability was excellent in both treatments.


Asunto(s)
Compuestos de Alumbre/uso terapéutico , Balanitis/tratamiento farmacológico , Sulfato de Cobre/uso terapéutico , Sulfato de Zinc/uso terapéutico , Administración Tópica , Anciano , Método Doble Ciego , Exudados y Transudados , Prepucio , Humanos , Masculino , Persona de Mediana Edad , Cloruro de Sodio , Soluciones/uso terapéutico , Irrigación Terapéutica
6.
Anaesthesiol Intensive Ther ; 46(5): 350-60, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25432555

RESUMEN

Intravenous fluid administration is a medical intervention performed worldwide on a daily basis. Nevertheless, only a few physicians are aware of the characteristics of intravenous fluids and their possible effects on plasma acid-base equilibrium. According to Stewart's theory, pH is independently regulated by three variables: partial pressure of carbon dioxide, strong ion difference (SID), and total amount of weak acids (ATOT). When fluids are infused, plasma SID and ATOT tend toward the SID and ATOT of the administered fluid. Depending on their composition, fluids can therefore lower, increase, or leave pH unchanged. As a general rule, crystalloids having a SID greater than plasma bicarbonate concentration (HCO3-) cause an increase in plasma pH (alkalosis), those having a SID lower than HCO3- cause a decrease in plasma pH (acidosis), while crystalloids with a SID equal to HCO3- leave pH unchanged, regardless of the extent of the dilution. Colloids and blood components are composed of a crystalloid solution as solvent, and the abovementioned rules partially hold true also for these fluids. The scenario is however complicated by the possible presence of weak anions (albumin, phosphates and gelatins) and their effect on plasma pH. The present manuscript summarises the characteristics of crystalloids, colloids, buffer solutions and blood components and reviews their effect on acid-base equilibrium. Understanding the composition of intravenous fluids, along with the application of simple physicochemical rules best described by Stewart's approach, are pivotal steps to fully elucidate and predict alterations of plasma acid-base equilibrium induced by fluid therapy.


Asunto(s)
Equilibrio Ácido-Base/efectos de los fármacos , Transfusión de Componentes Sanguíneos/efectos adversos , Transfusión de Componentes Sanguíneos/métodos , Coloides/efectos adversos , Coloides/uso terapéutico , Soluciones Isotónicas/efectos adversos , Soluciones Isotónicas/uso terapéutico , Soluciones/efectos adversos , Soluciones/uso terapéutico , Coloides/administración & dosificación , Soluciones Cristaloides , Fluidoterapia , Humanos , Infusiones Intravenosas , Soluciones Isotónicas/administración & dosificación , Soluciones/administración & dosificación , Agua/metabolismo
7.
Anesth Analg ; 117(3): 614-621, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23921656

RESUMEN

BACKGROUND: One small study suggests that gargling with licorice before induction of anesthesia reduces the risk of postoperative sore throat. Double-lumen tubes are large and thus especially likely to provoke sore throats. We therefore tested the hypothesis that preoperative gargling with licorice solution prevents postoperative sore throat and postextubation coughing in patients intubated with double-lumen tubes. METHODS: We enrolled 236 patients having elective thoracic surgery who required intubation with a double-lumen endotracheal tube. Patients were randomly assigned to gargle 5 minutes before induction of anesthesia for 1 minute with: (1) Extractum Liquiritiae Fluidum (licorice 0.5 g); or (2) Sirupus Simplex (sugar 5 g); each diluted in 30 mL water. Sore throat and postextubation coughing were evaluated 30 minutes, 90 minutes, and 4 hours after arrival in the postanesthesia care unit, and the first postoperative morning using an 11-point Likert scale by an investigator blinded to treatment. RESULTS: The incidence of postoperative sore throat was significantly reduced in patients who gargled with licorice rather than sugar-water: 19% and 36% at 30 minutes, 10% and 35% at 1.5 hours, and 21% and 45% at 4 hours, respectively. The corresponding estimated treatment effects (relative risks) were 0.54 (95% CI, 0.30-0.99, licorice versus sugar-water; P = 0.005), 0.31 (0.14-0.68) (P < 0.001), and 0.48 (0.28-0.83) (P < 0.001). CONCLUSION: Licorice gargling halved the incidence of sore throat. Preinduction gargling with licorice appears to be a simple way to prevent a common and bothersome complication.


Asunto(s)
Extubación Traqueal/efectos adversos , Carbohidratos/uso terapéutico , Tos/etiología , Tos/prevención & control , Glycyrrhiza , Faringitis/etiología , Faringitis/prevención & control , Complicaciones Posoperatorias/prevención & control , Administración Oral , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anestesia General , Carbohidratos/efectos adversos , Cuidados Críticos , Método Doble Ciego , Femenino , Glycyrrhiza/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Dolor Postoperatorio/prevención & control , Tamaño de la Muestra , Soluciones/efectos adversos , Soluciones/uso terapéutico , Adulto Joven
8.
J Pediatr Surg ; 46(12): 2376-82, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22152886

RESUMEN

Microvillous inclusion disease is a congenital intestinal epithelial cell disorder leading to lifelong intestinal failure. In this report, we discuss the use of a fish oil-based lipid emulsion in the treatment of 3 patients with microvillous inclusion disease who developed parenteral nutrition-associated liver disease.


Asunto(s)
Colestasis/terapia , Emulsiones Grasas Intravenosas/uso terapéutico , Aceites de Pescado/uso terapéutico , Síndromes de Malabsorción/terapia , Mucolipidosis/terapia , Nutrición Parenteral/efectos adversos , Fosfolípidos/efectos adversos , Complicaciones Posoperatorias/terapia , Aceite de Soja/efectos adversos , Aminoácidos/uso terapéutico , Bilirrubina/sangre , Lactancia Materna , Proteína C-Reactiva/análisis , Preescolar , Colestasis/sangre , Colestasis/etiología , Diarrea Infantil/etiología , Diarrea Infantil/terapia , Electrólitos/uso terapéutico , Emulsiones/efectos adversos , Emulsiones Grasas Intravenosas/efectos adversos , Glucosa/uso terapéutico , Humanos , Cuerpos de Inclusión , Recién Nacido , Recien Nacido Prematuro , Enfermedades del Prematuro/cirugía , Intestinos/trasplante , Hepatopatías/etiología , Hepatopatías/terapia , Síndromes de Malabsorción/complicaciones , Síndromes de Malabsorción/cirugía , Masculino , Microvellosidades/patología , Mucolipidosis/complicaciones , Mucolipidosis/cirugía , Soluciones para Nutrición Parenteral/uso terapéutico , Complicaciones Posoperatorias/sangre , Complicaciones Posoperatorias/etiología , Soluciones/uso terapéutico , Trasplante Homólogo , Triglicéridos
9.
Braz. j. med. biol. res ; 42(11): 1027-1034, Nov. 2009. ilus, tab
Artículo en Inglés | LILACS | ID: lil-529095

RESUMEN

Nutritional substances associated to some hormones enhance liver regeneration when injected intraperitoneally, being denominated hepatotrophic factors (HF). Here we verified if a solution of HF (glucose, vitamins, salts, amino acids, glucagon, insulin, and triiodothyronine) can revert liver cirrhosis and how some extracellular matrices are affected. Cirrhosis was induced for 14 weeks in 45 female Wistar rats (200 mg) by intraperitoneal injections of thioacetamide (200 mg/kg). Twenty-five rats received intraperitoneal HF twice a day for 10 days (40 mL·kg-1·day-1) and 20 rats received physiological saline. Fifteen rats were used as control. The HF applied to cirrhotic rats significantly: a) reduced the relative mRNA expression of the genes: Col-α1 (-53 percent), TIMP-1 (-31.7 percent), TGF-β1 (-57.7 percent), and MMP-2 (-41.6 percent), whereas Plau mRNA remained unchanged; b) reduced GGT (-43.1 percent), ALT (-17.6 percent), and AST (-12.2 percent) serum levels; c) increased liver weight (11.3 percent), and reduced liver collagen (-37.1 percent), regenerative nodules size (-22.1 percent), and fibrous septum thickness. Progranulin protein (immunohistochemistry) and mRNA (in situ hybridization) were found in fibrous septa and areas of bile duct proliferation in cirrhotic livers. Concluding, HF improved the histology and serum biochemistry of liver cirrhosis, with an important reduction of interstitial collagen and increased extracelullar matrix degradation by reducing profibrotic gene expression.


Asunto(s)
Animales , Femenino , Ratas , Matriz Extracelular/metabolismo , Cirrosis Hepática Experimental/terapia , Apoyo Nutricional/métodos , Soluciones/uso terapéutico , Aminoácidos/administración & dosificación , Aminoácidos/uso terapéutico , Glucosa/administración & dosificación , Glucosa/uso terapéutico , Hormonas/administración & dosificación , Hormonas/uso terapéutico , Inmunohistoquímica , Hibridación in Situ , Inyecciones Intraperitoneales , Cirrosis Hepática Experimental/metabolismo , Cirrosis Hepática Experimental/patología , Ratas Wistar , Sales (Química)/administración & dosificación , Sales (Química)/uso terapéutico , Soluciones/administración & dosificación , Tioacetamida , Vitaminas/administración & dosificación , Vitaminas/uso terapéutico
10.
Braz J Med Biol Res ; 42(11): 1027-34, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19784507

RESUMEN

Nutritional substances associated to some hormones enhance liver regeneration when injected intraperitoneally, being denominated hepatotrophic factors (HF). Here we verified if a solution of HF (glucose, vitamins, salts, amino acids, glucagon, insulin, and triiodothyronine) can revert liver cirrhosis and how some extracellular matrices are affected. Cirrhosis was induced for 14 weeks in 45 female Wistar rats (200 mg) by intraperitoneal injections of thioacetamide (200 mg/kg). Twenty-five rats received intraperitoneal HF twice a day for 10 days (40 mL.kg-1.day-1) and 20 rats received physiological saline. Fifteen rats were used as control. The HF applied to cirrhotic rats significantly: a) reduced the relative mRNA expression of the genes: Col-alpha1 (-53%), TIMP-1 (-31.7%), TGF-beta1 (-57.7%), and MMP-2 (-41.6%), whereas Plau mRNA remained unchanged; b) reduced GGT (-43.1%), ALT (-17.6%), and AST (-12.2%) serum levels; c) increased liver weight (11.3%), and reduced liver collagen (-37.1%), regenerative nodules size (-22.1%), and fibrous septum thickness. Progranulin protein (immunohistochemistry) and mRNA (in situ hybridization) were found in fibrous septa and areas of bile duct proliferation in cirrhotic livers. Concluding, HF improved the histology and serum biochemistry of liver cirrhosis, with an important reduction of interstitial collagen and increased extracelullar matrix degradation by reducing profibrotic gene expression.


Asunto(s)
Matriz Extracelular/metabolismo , Cirrosis Hepática Experimental/terapia , Apoyo Nutricional/métodos , Soluciones/uso terapéutico , Aminoácidos/administración & dosificación , Aminoácidos/uso terapéutico , Animales , Femenino , Glucosa/administración & dosificación , Glucosa/uso terapéutico , Hormonas/administración & dosificación , Hormonas/uso terapéutico , Inmunohistoquímica , Hibridación in Situ , Inyecciones Intraperitoneales , Cirrosis Hepática Experimental/metabolismo , Cirrosis Hepática Experimental/patología , Ratas , Ratas Wistar , Sales (Química)/administración & dosificación , Sales (Química)/uso terapéutico , Soluciones/administración & dosificación , Tioacetamida , Vitaminas/administración & dosificación , Vitaminas/uso terapéutico
11.
AAPS PharmSci ; 5(1): E5, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12713277

RESUMEN

The development of vaginal medications, especially antifungal medications, requires that the drug is solubilized as well as retained at or near the mucosa for sufficient periods of time to ensure adequate bioavailability. Itraconazole is a broad-spectrum antifungal agent, which has been used for some time orally and intravenously but for which a vaginal formulation has not yet been developed. We present here a novel itraconazole formulation intended for vaginal use based on hydroxypropyl-beta-cyclodextrin (HPbetaCD), a functional excipient that increases drug solubility and generates a mucoadhesive system in the presence of other ingredients. An aqueous phase was prepared by solubilizing itraconazole with HCl in the presence of propylene glycol and then adding an aqueous solution of HPbetaCD. After pH adjustment, the itraconazole/HPbetaCD solution was added to the oil phase (paraffin oil, trihydroxystearate, and cetyl dimethicon copolyol) and the desired cream containing 1%, 2%, and 2.5% drug obtained by homogenization. Primary irritation studies and subchronic toxicity studies using a rabbit vaginal model indicated that the formulation was safe, well tolerated, and retained in the vaginal space. Clinical investigations indicated that application of 5 g of a 2% cream was very well tolerated and itraconazole was not systemically absorbed. Additional studies in women found that the itraconazole cream was highly effective in reducing or eliminating fungal cultures with few adverse effects. These studies suggested that an HPbetaCD-based, emulsified wax cream formulation was a useful and effective dosage form for treating vaginal candidiasis.


Asunto(s)
Itraconazol/química , Itraconazol/uso terapéutico , beta-Ciclodextrinas , 2-Hidroxipropil-beta-Ciclodextrina , Animales , Antifúngicos/administración & dosificación , Antifúngicos/química , Antifúngicos/uso terapéutico , Disponibilidad Biológica , Candida albicans/efectos de los fármacos , Candidiasis/tratamiento farmacológico , Ciclodextrinas/administración & dosificación , Ciclodextrinas/síntesis química , Ciclodextrinas/uso terapéutico , Formas de Dosificación , Evaluación Preclínica de Medicamentos , Estabilidad de Medicamentos , Femenino , Humanos , Itraconazol/administración & dosificación , Itraconazol/toxicidad , Conejos , Solubilidad , Soluciones/química , Soluciones/uso terapéutico , Cremas, Espumas y Geles Vaginales/administración & dosificación , Cremas, Espumas y Geles Vaginales/uso terapéutico , Enfermedades Vaginales/tratamiento farmacológico , Enfermedades Vaginales/microbiología
12.
Appl Nurs Res ; 13(2): 83-91, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10842904

RESUMEN

Tap water and soapsuds are common enema solutions, but little is known about their effectiveness. Consequently, nurses have no guidance when choosing the best enema for a given patient. In this study, liver transplant patients were given either a tap water or soapsuds enema preoperatively. Amount of enema instilled into the colon and output were measured. Soapsuds enemas produced significantly greater output than tap water and were equally well tolerated. Most subjects who received tap water enemas retained more fluid than was eliminated. Based on these findings, nurses should use caution when giving repeated enemas to patients sensitive to large fluid loads.


Asunto(s)
Colon/metabolismo , Enema/métodos , Jabones/farmacocinética , Soluciones/farmacocinética , Agua/metabolismo , Adulto , Anciano , Colon/fisiología , Enema/efectos adversos , Femenino , Humanos , Mucosa Intestinal/fisiología , Masculino , Persona de Mediana Edad , Dolor/etiología , Cuidados Preoperatorios , Jabones/uso terapéutico , Soluciones/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA